Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 428 of 5804
-
New cocktail aims to tame dangerous leukemia in High-Risk patients
Disease control OngoingThis study aims to evaluate the safety and effectiveness of combining venetoclax with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) in patients with newly diagnosed acute promyelocytic leukemia (APL) who have very high white blood cell counts. APL is a rare type of bl…
Phase: NA • Sponsor: Anhui Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hepatitis b drug shows promise in large trial
Disease control OngoingUsingTAF as the control, the nvestigators aim to further explore the efficacy and safety of different dosages of HTS in the treatment of patients with chronic hepatitis B; ultimately, the nvestigators determine the optimal recommended dosage of HTS to provide a basis for Phase II…
Phase: PHASE2, PHASE3 • Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Brain-Wash breakthrough? new trial takes on deadly ventriculitis
Disease control Recruiting nowVentriculitis is a severe infectious disease of the central nervous system with diverse etiologies. Currently, the treatment for ventriculitis is challenging, with poor prognosis. The mortality rate of ventriculitis is generally reported to be higher than 30%, with the highest re…
Phase: NA • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New combo therapy aims to beat childhood lymphoma
Disease control Recruiting nowThe purpose of this study is to test whether intensive chemotherapy combined with early, adequate, and intensive use of Rituximab for aggressive B-NHL in children and adolescents can improve the EFS and OS compared with the historical study CCCG-BNHL-2015.
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Cord blood cells take on stomach cancer: new hope in Late-Stage trial
Disease control Recruiting nowThis project employs a prospective, double-blind, randomized controlled trial methodology to comparatively analyze the safety and survival outcomes of human umbilical cord blood RAK cells applied in advanced gastric cancer. Firstly, the maximum tolerated dose (MTD) of RAK cell th…
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for lymphoma patients: drug combo plus optional transplant
Disease control Recruiting nowThis multicenter, open-label, trial aims to evaluate the efficacy and safety of orelabrutinib in combination with rituximab with optional autologous hematopoietic stem cell transplantation in patients with non-high-risk mantle cell lymphoma (MCL). The primary objective is to asse…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
AI-Powered ECG alerts could catch silent heart rhythm problems before they strike
Diagnosis Recruiting nowOur study aimed to use an AF-predict AI-ECG alert system to help physicians identify patients who need to wear a continuous cardiac rhythm monitor for new diagnoses of atrial fibrillation (AF), atrial flutter (AFL), or atrial arrhythmia with high AF risk, including premature atri…
Phase: NA • Sponsor: National Defense Medical Center, Taiwan • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Fast brain zaps show promise for suicidal teens in new trial
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a fast-acting brain stimulation treatment called transcranial magnetic stimulation (TMS) can help people with depression and suicidal thoughts. The treatment is non-invasive (does not involve surgery or medications), is given over 5 …
Phase: NA • Sponsor: University of California, Davis • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Less cutting, same cure? new trial tests smaller surgery for rectal cancer
Disease control OngoingThe goal of this clinical trial is to learn evaluate the safety and efficacy of reduced surgical resection margins in patients with local advanced upper rectal or rectosigmoid junction tumors who met the ycT≤3N0M0 regression following neoadjuvant therapy. The main questions it ai…
Phase: NA • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New chemo cocktail aims to outperform standard care in colorectal cancer
Disease control Recruiting nowTo explore the safety and efficacy of NALIRIFOX plus targeted therapy versus FOLFOX plus targeted therapy as first-line treatment for metastatic colorectal cancer.
Phase: PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
5,000 smokers to test new digital nudge vs. standard care in cancer prevention trial
Prevention OngoingThe purpose of this study is to evaluate the comparative effectiveness of two different informatics-enabled implementation strategies on increasing tobacco treatment and improving smoking cessation rates for cancer control and prevention. This will be done via a two-arm pragmatic…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jul 12, 2026 00:00 UTC
-
New drug shows promise in shrinking lung tumors before surgery
Disease control Recruiting nowThis is an exploratory clinical study focusing on the neoadjuvant treatment of non-small cell lung cancer (NSCLC). The study primarily aims to compare the efficacy and safety of Ivonescimab, a novel PD-1/VEGF bispecific antibody, with those of conventional PD-1 inhibitors. Beyond…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New universal CAR-T therapy targets tough multiple myeloma cases
Disease control TerminatedThis study is a single-arm, investigator-initiated clinical trial. The primary objective is to evaluate the safety and preliminary efficacy of administering universal BCMA CAR-T cells to subjects with refractory and relapsed multiple myeloma. Eligible participants will undergo FC…
Phase: EARLY_PHASE1 • Sponsor: Wondercel Biotech (ShenZhen) • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Stool test may detect stomach cancer risk before symptoms appear
Diagnosis Recruiting nowThis is a prospective study designed to compare the performance of fecal H. pylori gastric cancer susceptibility analysis and the gastric cancer risk questionnaire for the early detection of gastric cancer. The primary objective is to assess whether each method, individually or i…
Sponsor: Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
New hope for tough thyroid cancers: drug combo trial launches
Disease control Recruiting nowThis is a multicenter, open-label, multi-cohort Phase II exploratory study designed to evaluate the efficacy and safety of sacituzumab tirumotecan with or without tislelizumab in patients with unresectable, locally advanced, or metastatic anaplastic thyroid carcinoma (ATC), poorl…
Phase: NA • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug cocktail aims to save lungs in scleroderma patients
Disease control Recruiting nowThe study includes adult patients with systemic sclerosis (SSc) with interstitial lung disease (ILD) to evaluate the efficacy and safety of nintedanib plus tocilizumab combination therapy compared to standard therapy (methotrexate, mycophenolate mofetil) for 56 weeks.
Phase: PHASE3 • Sponsor: National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
AI-Assisted surgery aims to improve brain bleed recovery
Disease control Recruiting nowThe effectiveness of traditional craniotomy in the treatment of intracerebral hemorrhage remains controversial. Minimally invasive surgery, specially, image-guided hematoma aspiration, proves to be effective and may have some advantages compared with craniotomy. This multicenter …
Phase: NA • Sponsor: Xiaolei Chen • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Triple therapy shrinks bile duct tumors, may enable surgery
Disease control Recruiting nowThis is a phase II, single-arm, prospective clinical trial designed to evaluate the efficacy and safety of neoadjuvant therapy combining stereotactic body radiotherapy (SBRT), GP chemotherapy (gemcitabine and cisplatin/oxaliplatin), and tislelizumab in patients with borderline re…
Phase: PHASE2 • Sponsor: Jinbo Yue • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Magic mushroom therapy tested for depression in chronic illness patients
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether psilocybin therapy can effectively treat depression and psychological distress in adult patients with COPD, ALS, MS, or APD who have at least 6 months life expectancy. The main questions it aims to answer are: * Can psilocyb…
Phase: PHASE2 • Sponsor: University Medical Center Groningen • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Immune cells engineered to fight lymphoma enter human testing
Disease control Recruiting nowThis is an open label clinical study: Phase Ia is a dose escalation phase, evaluating the safety, tolerability, RP2D, PK characteristics, and preliminary efficacy of IBR900 cell injection in the treatment of relapsed/refractory B-cell non Hodgkin lymphoma (NHL); Phase Ib is the d…
Phase: PHASE1 • Sponsor: Imbioray (Hangzhou) Biomedicine Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC